Immune system - P2 Flashcards
describe structure of human immunodeficiency virus (HIV)
capsid reverse transcriptase rna lipid envelope made of host cell cell membrane attachment proteins
Describe the replication of HIV in helper T cells
- HIV infects T helper cells (host cell) - HIV attachment protein attaches to a receptor on the helper T-cell membrane
- Virus lipid envelope fuses with cell surface membrane and capsid released into cell which uncoats, releasing RNA and reverse transcriptase into cytoplasm
- Viral DNA is made from viral RNA - Reverse transcriptase produces a complementary viral DNA strand from viral RNA template
- Double stranded DNA is made from this (DNA polymerase) - Viral DNA integrated into host cell’s DNA (by enzyme integrase)
- This remains latent for a long time in host cell until activated
- Host cell enzymes used to make viral proteins from viral DNA (within human DNA) → viral proteins assembled with viral RNA to make a new virus
- New virus bud from cell (taking some of cell surface membrane as envelope)
- Eventually kills helper T cells
- Most host cells are infected and process repeat
Explain how HIV causes the symptoms of AIDS – acquired immune deficiency syndrome
- Infects and kills helper T cells (host cell) as it multiplies rapidly
- T helper cells then can’t stimulate cytotoxic T cells, B cells and phagocytes → impaired immune response
- Immune system deteriorates
- More susceptible to infections
- Diseases that wouldn’t cause serious problems in healthy immune system are deadly (opportunistic infections) e.g. pneumonia
Explain why antibiotics are ineffective against viruses
- Antibiotics can’t enter human calls – but viruses exists in its host cell (they are acellular)
- Viruses don’t have own metabolic reactions e.g. ribosomes (use of the host cell’s) which antibiotics target
- If we did use them… act as a selection pressure + gene mutation = resistant strain of bacteria via natural selection → reducing effectiveness of antibiotics and waste money
`
why does not being able to produce immune response due to aids lead to death
infected by pathogen
pathogen reproduces in host cell
damages cell
releases toxins
what is a monoclonal antibody
- Monoclonal antibody = antibody produced from a single group of genetically identical (clones) B cells / plasma cells
describe use of monoclonal antibodies
- Monoclonal antibody = antibody produced from a single group of genetically identical (clones) B cells / plasma cells
- Identical structure
- Bind to specific complimentary antigen
- Have a binding site / variable region with a specific tertiary structure / shape
- Only one complementary antigen will fit
why are monoclonal antibodies useful in medicine
- Only bind to specific target molecules / antigens because…
- Antibodies have a specific tertiary structure (binding site / variable region) that’s complementary to a specific antigen which can bind/fit to the antibody
Explain how Monoclonal antibodies are used in targeting medication to specific cell types by attaching a therapeutic drug to an antibody e.g. in the treatment of cancer cells
- Monoclonal antibodies made to be complementary to antigens specific to cancer cells → cancer cells are abnormal body cells with different antigens (tumour markers)
- Anti-cancer drug attached to antibody
- Antibody binds / attaches to cancer cells (forming antigen-antibody complex)
- Delivers attached anti-cancer drug directly to specific cancer cells so drug accumulates → fewer side effects e.g. fewer normal body cells killed
Explain the use of antibodies in the ELISA
- Can determine if a patient has
a) Antibodies to a certain antigen
b) Antigen to a certain antibody - Used to diagnose diseases or allergies (e.g. HIV / Lactose intolerance)
Explain why the use of controls when performing the ELISA test is necessary
- Controls enable a comparison with the test
- To show that:
- Only the enzyme and nothing else causes colour change
- Washing is effective and all unbound antibody is washed away
ethical issues associated with the use of monoclonal antibodies
- Animals are involved in the production of monoclonal antibodies
- Although effective treatment for cancer and diabetes has caused deaths when used in treatment of Multiple Sclerosis
- Patients need to be informed of risk and benefits before treatment so they can make informed decisions